Hydreight Announces Normal Course Issuer Bid

Core Viewpoint - Hydreight Technologies Inc. announces a normal course issuer bid to purchase up to 4,951,189 common shares, representing approximately 9.27% of the outstanding shares, to enhance shareholder value and stabilize market pricing [1] Company Overview - Hydreight Technologies Inc. is a provider of digital health infrastructure and on-demand healthcare services across the United States, aiming to build one of the largest mobile clinic networks [1] - The company has developed a proprietary platform that connects over 3,000 nurses and 300 doctors, facilitating healthcare services directly to patients in various settings [1] - Hydreight's platform includes integrated tools for managing patient data, accounting, and sales, empowering healthcare professionals to operate independently [1] Normal Course Issuer Bid Details - The issuer bid will commence on March 12, 2026, and terminate on March 11, 2027, or earlier if completed [1] - The bid will be conducted in accordance with applicable securities laws and will be funded from existing working capital [1] - The company believes that the current market price does not reflect its business strength and growth potential, justifying the share buyback [1] VSDHOne Platform - Hydreight launched the VSDHOne platform in partnership with Victory Square Technologies, aimed at simplifying entry for businesses into the online healthcare space [1] - The platform offers compliant healthcare services, including GLP-1s, peptides, and personalized treatments, allowing businesses to launch direct-to-consumer healthcare brands quickly [1] - VSDHOne provides a comprehensive solution, reducing the time and costs associated with entering the online healthcare market [1]